CompletedPHASE1, PHASE2NCT04471519

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bharat Biotech International Limited
Principal Investigator
Dr. Savita Verma, MBBS, MD
PGIMS, Rohtak
Intervention
BBV152A - Phase I(biological)
Enrollment
755 target
Eligibility
12-65 years · All sexes
Timeline
20202021

Study locations (12)

Collaborators

Indian Council of Medical Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04471519 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials